NCT03460522View on ClinicalTrials.gov

Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL

PHASE2RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 2, 2018

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Precursor Cell Lymphoblastic Leukemia
Interventions
DRUG

Inotuzumab ozogamicin

Patients will receive standard of care chemotherapy (only maintenance) after Inotuzumab Ozogamicin.

Trial Locations (14)

40225

RECRUITING

University Hospital Düsseldorf, Düsseldorf

48149

RECRUITING

University of Muenster, Münster

60590

RECRUITING

University Hospital of Frankfurt, Frankfurt

69120

RECRUITING

Universitätsklinikum Heidelberg, Heidelberg

Unknown

RECRUITING

Klinikum Augsburg, Augsburg

RECRUITING

Universität Bonn, Bonn

RECRUITING

Klinikum Chemnitz gGmbH, Chemnitz

RECRUITING

Uniklinik Dresden, Dresden

RECRUITING

Universität Erlangen, Erlangen

RECRUITING

Univeristätsklinikum Essen, Essen

RECRUITING

Universitätsklinikum Freiburg, Freiburg im Breisgau

RECRUITING

Uniklinikum, Jena

RECRUITING

Klinikum Nürnberg Nord, Nuremberg

RECRUITING

Robert - Bosch - Krankenhaus, Stuttgart

All Listed Sponsors
lead

Nicola Goekbuget

OTHER